# US 2011/0262513 A1 · Anti-viral member

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2011/0262513 A1
- Document ID: US20110262513A1
- Status: Published application
- Kind: A1
- Application number: 13/142,118
- Filed: 2009-12-28
- Published: 2011-10-27
- Earliest claimed: 2008-12-26
- Assignees: Nbc Meshtec Inc.
- Inventors: Yoshie Fujimori; Tsuruo Nakayama; Yoko Fukui
- Web page: https://patentgrep.com/patent/US20110262513A1

## CPC

- D06M 11/13: Ammonium halides or halides of elements of Groups 1 or 11 of the Periodic Table
- A01N 25/34: Shaped forms, e.g. sheets, not provided for in any other sub-group of this main group
- A01N 59/20: Copper
- A61K 39/42: viral
- D06M 11/42: Oxides or hydroxides of copper, silver or gold
- D06M 11/53: with hydrogen sulfide or its salts; with polysulfides
- D06M 11/67: with cyanogen or compounds thereof, e.g. with cyanhydric acid, cyanic acid, isocyanic acid, thiocyanic acid, isothiocyanic acid or their salts, or with cyanamides; with carbamic acid or its salts (with dicyanamides D06M13/432)
- D06M 13/188: Monocarboxylic acids; Anhydrides, halides or salts thereof {(D06M13/1845 takes precedence)}
- D06M 13/513: with at least one carbon-silicon bond
- D06M 16/00: Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic
- D06M 23/08: Processes in which the treating agent is applied in powder or granular form (adhesives for multi-layer textile fabrics D06M17/00)
- D06M: TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Disclosed is an anti-viral member which can inactivate a virus. Specifically disclosed is an anti-viral member which is characterized by comprising a base material, univalent copper compound microparticles, and inorganic microparticles which are provided for the purpose of retaining the univalent copper compound microparticles on the base material and each of which has a silane monomer bound to the surface thereof via a chemical bond, wherein the inorganic microparticles are bound to one another via chemical bonds formed between the silane monomers provided on the surfaces thereof, and each of the inorganic microparticles is bound to the base material via a chemical bond between the silane monomer and the base material to form spaces in which the univalent copper compound microparticles are to be retained. The anti-viral member has an extremely high anti-viral activity compared to those achieved by the conventional binder immobilization techniques, and is applicable to various materials or various products to which the materials are applied.

## Claims

### Claim 1

An antiviral member, comprising:
a substrate;
univalent copper compound particles; and
a group of inorganic particles which are for supporting the univalent copper compound particles on the substrate and which have a silane monomer chemically bonded to a surface thereof, wherein
the inorganic particles having the silane monomer on the surface thereof are bonded to each other via chemical bonds formed between the silane monomers provided on the surface of the inorganic particles, and the group of inorganic particles are bonded to the substrate due to the chemical bonds between the silane monomers on the surface of the inorganic particles and the substrate,
whereby the group of inorganic particles forms spaces for supporting the univalent copper compound particles.

### Claim 2

An antiviral member, comprising:
coating a substrate with a slurry in which inorganic particles having a silane monomer, which has an unsaturated bonding site or a reactive functional group, chemically bonded to a surface thereof and univalent copper compound particles are dispersed,
making the inorganic particles having the silane monomer chemically bonded to the surface thereof be bonded to each other by chemical bonds that are formed between the silane monomers on the surface of the inorganic particles, and making the group of inorganic particles having the silane monomer chemically bonded to the surface thereof be bonded to the substrate by chemical bonds formed between the unsaturated bonding site or the reactive functional group of the silane monomers and the substrate surface, whereby spaces for supporting the univalent copper compound particles is formed, and
supporting the univalent copper compound particles in the space.

### Claim 3 (depends on 1)

The antiviral member according to claim 1, wherein:
the chemical bonds between the silane monomers and the inorganic particles are covalent bonds formed by dehydration condensation, the chemical bonds among the silane monomers are covalent bonds formed by radical polymerization, and
the chemical bonds between the silane monomers and the substrate are covalent bonds formed by graft polymerization.

### Claim 4 (depends on 3)

The antiviral member according to claim 3, wherein the radical polymerization is radiation-induced radical polymerization, and the graft polymerization is radiation-induced graft polymerization.

### Claim 5 (depends on 1)

The antiviral member according to claim 1, wherein the univalent copper compound particles are bonded to the inorganic particles via a binder component which is a monomer, an oligomer, or a mixture thereof.

### Claim 6 (depends on 1)

The antiviral member according to claim 1, wherein the univalent copper compound particles are formed of a chloride, an acetate, a sulfide, an iodide, a bromide, a peroxide, an oxide, a hydroxide, a cyanide, a thiocyanate or a mixture thereof.

### Claim 7 (depends on 1)

The antiviral member according to claim 1, wherein the univalent copper compound particles are formed of at least one kind selected from the group consisting of CuCl, CuCH3COO, CuI, CuBr, Cu2O, CuOH, Cu2S, CuCN, and CuSCN.

### Claim 8 (depends on 1)

The antiviral member according to claim 1, wherein a content of the univalent copper compound particles is, with respect to a total solid content on the substrate, 0.1 mass % to 60 mass %.

### Claim 9 (depends on 1)

The antiviral member according to claim 1, wherein the substrate is a fibrous structure.

### Claim 10 (depends on 2)

The antiviral member according to claim 2, wherein:
the chemical bonds between the silane monomers and the inorganic particles are covalent bonds formed by dehydration condensation, the chemical bonds among the silane monomers are covalent bonds formed by radical polymerization, and
the chemical bonds between the silane monomers and the substrate are covalent bonds formed by graft polymerization.

### Claim 11 (depends on 10)

The antiviral member according to claim 10, wherein the radical polymerization is radiation-induced radical polymerization, and the graft polymerization is radiation-induced graft polymerization.

### Claim 12 (depends on 2)

The antiviral member according to claim 2, wherein the univalent copper compound particles are bonded to the inorganic particles via a binder component which is a monomer, an oligomer, or a mixture thereof.

### Claim 13 (depends on 2)

The antiviral member according to claim 2, wherein the univalent copper compound particles are formed of a chloride, an acetate, a sulfide, an iodide, a bromide, a peroxide, an oxide, a hydroxide, a cyanide, a thiocyanate or a mixture thereof.

### Claim 14 (depends on 2)

The antiviral member according to claim 2, wherein the univalent copper compound particles are formed of at least one kind selected from the group consisting of CuCl, CuCH3COO, CuI, CuBr, Cu2O, CuOH, Cu2S, CuCN, and CuSCN.

### Claim 15 (depends on 2)

The antiviral member according to claim 2, wherein a content of the univalent copper compound particles is, with respect to a total solid content on the substrate, 0.1 mass % to 60 mass %.

### Claim 16 (depends on 2)

The antiviral member according to claim 2, wherein the substrate is a fibrous structure.
